Skip to main navigation Skip to search Skip to main content

Patogenia de la hepatopatía grasa no alcohólica primaria

Translated title of the contribution: Pathogenesis of primary nonalcoholic fatty liver disease

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

The challenges of growing prevalence and evident trend to progressive damage of primary nonalcoholic fatty liver disease confront a poorly understood pathogenesis. It appears to develop in two steps. First, a high adipocyte protein production in the context of a silent inflammatory background causes insulin resistance in adipose tissue. It leads both to lipolysis, with increase of the circulating and hepatic uptake of free fatty acids, and hyperinsulinemia. Within hepatocytes, the subsequent lipogenesis, together with a decreased secretion of lipoproteins, induces an accumulation of excessive hepatic triglycerides (steatosis), impliying some oxidative damage, but it remain balanced by uncoupling protein upregulation and antioxidant systems activation. Second, a more forceful fat catabolism by beta and omega oxidation results in respiratory chain hyperactivity with overproduction of free radicals and reactive oxygen species that exceed the antioxidant capacity. These agents lead to hepatocellular injury and necrosis, inflammatory infiltration and fibrosis (steatohepatitis) through induction of Fas ligand and cytokines (tumor necrosis factor α, transforming growth factor β, interleukin-8), and lipid peroxidation and by-products (malondialdehyde and 4-hydroxynonenal). Other mechanisms (hepatic iron, Kupffer cells dysfunction or endotoxemia) play uncertain roles.

Translated title of the contributionPathogenesis of primary nonalcoholic fatty liver disease
Original languageSpanish
Article number96.108
Pages (from-to)668-677
Number of pages10
JournalMedicina Clinica
Volume124
Issue number17
DOIs
StatePublished - 07 May 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pathogenesis of primary nonalcoholic fatty liver disease'. Together they form a unique fingerprint.

Cite this